Br.[NH:2]([C:4]1[NH:5][CH2:6][CH2:7][N:8]=1)[NH2:3].Br.[OH:10][C@H:11]1[CH2:31][CH2:30][C@@:29]2([CH3:32])[C@H:13]([CH2:14][CH2:15][C@@H:16]3[C@@H:28]2[CH2:27][CH2:26][C@@:25]2([CH3:33])[C@:17]3([OH:34])[CH2:18][CH2:19][C@@H:20]2/[CH:21]=[CH:22]/[CH:23]=O)[CH2:12]1>O.O1CCOCC1>[NH:8]1[CH2:7][CH2:6][N:5]=[C:4]1[NH:2]/[N:3]=[CH:23]/[CH:22]=[CH:21]/[C@H:20]1[CH2:19][CH2:18][C@:17]2([OH:34])[C@H:16]3[C@H:28]([CH2:27][CH2:26][C@:25]12[CH3:33])[C@:29]1([CH3:32])[C@@H:13]([CH2:12][C@@H:11]([OH:10])[CH2:31][CH2:30]1)[CH2:14][CH2:15]3A solution of 1.19 g of 2-hydrazino-2-imidazoline hydrobromide in 20 ml of water and 60 ml of dioxane was made acid to pH 3 with 0.1N HBr. A solution of 2.08 g of (E)-3β,14β-dihydroxy-5β-pregn-20-ene-21-carboxaldehyde (Fullerton D. S. et al., J. Med. Chem., 1976, 19, 1330) in 25 ml of dioxane was added at room temperature. After 3 days, the solution was evaporated to dryness under reduced pressure. The crude product was purified by flash chromatography (SiO2) using chloroform/methanol/28% ammonium hydroxide 90/10/1 as the eluant; the fractions containing the title compound were collected and evaporated to dryness. The residue was ground with ethyl acetate and ethanol to give 1.54 g of the title compound (I-ac) as a white solid.